Gene · 7517
Papers2,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2. | Int J Mol Sci | 2023 | 37298108 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia. | Blood Cancer J | 2023 | 37286545 | PubTator, text mining | PubMed |
| Association between single nucleotide polymorphisms in DNA repair genes and the efficacy of radiotherapy in nasopharyngeal carcinoma patients. | Contemp Oncol (Pozn) | 2023 | 37266339 | PubTator, text mining | PubMed |
| Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C. | Cancer Res | 2023 | 37253112 | PubTator, text mining | PubMed |
| Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity. | Radiat Oncol | 2023 | 37226275 | PubTator, text mining | PubMed |
| Systematic evaluation of the association between a missense variant in XRCC3 gene splicing site and the pathogenesis of ovarian cancer. | Biosci Rep | 2023 | 37212185 | PubTator, text mining | PubMed |
| Identification of crucial genes involved in thyroid cancer development. | J Egypt Natl Canc Inst | 2023 | 37211566 | PubTator, text mining | PubMed |
| Noncanonical Roles of RAD51. | Cells | 2023 | 37190078 | PubTator, text mining | PubMed |
| Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil. | Biomedicines | 2023 | 37189700 | PubTator, text mining | PubMed |
| Emerging strategies for cancer therapy by ATR inhibitors. | Cancer Sci | 2023 | 37189251 | PubTator, text mining | PubMed |
| Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus. | Mol Ther Nucleic Acids | 2023 | 37187708 | PubTator, text mining | PubMed |
| Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. | J Gynecol Oncol | 2023 | 37170728 | PubTator, text mining | PubMed |
| A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy. | Bioact Mater | 2023 | 37122898 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| A novel role of TRIM28 B box domain in L1 retrotransposition and ORF2p-mediated cDNA synthesis. | Nucleic Acids Res | 2023 | 37070200 | PubTator, text mining | PubMed |
| Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. | Nat Commun | 2023 | 37029129 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery. | Front Pharmacol | 2023 | 37007005 | PubTator, text mining | PubMed |
| XRCC3 and NBS1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population. | J Cancer Res Ther | 2023 | 37006067 | PubTator, text mining | PubMed |
| Hyperextended telomeres promote formation of C-circle DNA in telomerase positive human cells. | J Biol Chem | 2023 | 37003504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7517/papers?page=7